Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Sei-ichi Yusa"'
Publikováno v:
Viruses, Vol 4, Iss 11, Pp 3109-3131 (2012)
The human cellular prion protein (PrPC) is a glycosylphosphatidylinositol (GPI) anchored membrane glycoprotein with two N-glycosylation sites at residues 181 and 197. This protein migrates in several bands by Western blot analysis (WB). Interestingly
Externí odkaz:
https://doaj.org/article/85f32d601c834ee4967a64094315b0fa
Autor:
José B Oliveira-Martins, Sei-ichi Yusa, Anna Maria Calella, Claire Bridel, Frank Baumann, Paolo Dametto, Adriano Aguzzi
Publikováno v:
PLoS ONE, Vol 5, Iss 2, p e9107 (2010)
The cellular form of the prion protein, PrP(C), undergoes extensive proteolysis at the alpha site (109K [see text]H110). Expression of non-cleavable PrP(C) mutants in transgenic mice correlates with neurotoxicity, suggesting that alpha-cleavage is im
Externí odkaz:
https://doaj.org/article/0ecdcbec951c4e6bb264c6986e039dbe
Autor:
Hisao Tajiri, Toshifumi Ohkusa, Haruo Sugiyama, Jianlin Gong, Shigetaka Shimodaira, Sei-ichi Yusa, Takefumi Ishidao, Masaki Ito, Yuko Kamata, Hideo Komita, Kazumi Hayashi, Shin Kan, Masahiro Ikegami, Satoru Yanagisawa, Yoichi Toyama, Takeyuki Misawa, Hiroshi Arakawa, Mikio Kajihara, Kan Uchiyama, Hiroo Imazu, Seita Koyama, Shunichi Odahara, Shintaro Tsukinaga, Shinji Yoshizaki, Masako Mori, Kazuki Takakura, Masato Okamoto, Sadamu Homma, Shigeo Koido
Supplementary Figure Legend from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24946cec609875410134b9f63799eb64
https://doi.org/10.1158/1078-0432.22456167.v1
https://doi.org/10.1158/1078-0432.22456167.v1
Autor:
Hisao Tajiri, Toshifumi Ohkusa, Haruo Sugiyama, Jianlin Gong, Shigetaka Shimodaira, Sei-ichi Yusa, Takefumi Ishidao, Masaki Ito, Yuko Kamata, Hideo Komita, Kazumi Hayashi, Shin Kan, Masahiro Ikegami, Satoru Yanagisawa, Yoichi Toyama, Takeyuki Misawa, Hiroshi Arakawa, Mikio Kajihara, Kan Uchiyama, Hiroo Imazu, Seita Koyama, Shunichi Odahara, Shintaro Tsukinaga, Shinji Yoshizaki, Masako Mori, Kazuki Takakura, Masato Okamoto, Sadamu Homma, Shigeo Koido
Adverse events during the first 3 courses of treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bf63170498758b4e6820caef557da88
https://doi.org/10.1158/1078-0432.22456155
https://doi.org/10.1158/1078-0432.22456155
Autor:
Hisao Tajiri, Toshifumi Ohkusa, Haruo Sugiyama, Jianlin Gong, Shigetaka Shimodaira, Sei-ichi Yusa, Takefumi Ishidao, Masaki Ito, Yuko Kamata, Hideo Komita, Kazumi Hayashi, Shin Kan, Masahiro Ikegami, Satoru Yanagisawa, Yoichi Toyama, Takeyuki Misawa, Hiroshi Arakawa, Mikio Kajihara, Kan Uchiyama, Hiroo Imazu, Seita Koyama, Shunichi Odahara, Shintaro Tsukinaga, Shinji Yoshizaki, Masako Mori, Kazuki Takakura, Masato Okamoto, Sadamu Homma, Shigeo Koido
Frequency of regulatory T cells or myeloid-derived suppressor cells in patients before and after therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43986c14f15f22e6eb718451d458758e
https://doi.org/10.1158/1078-0432.22456158.v1
https://doi.org/10.1158/1078-0432.22456158.v1
Autor:
Hisao Tajiri, Toshifumi Ohkusa, Haruo Sugiyama, Jianlin Gong, Shigetaka Shimodaira, Sei-ichi Yusa, Takefumi Ishidao, Masaki Ito, Yuko Kamata, Hideo Komita, Kazumi Hayashi, Shin Kan, Masahiro Ikegami, Satoru Yanagisawa, Yoichi Toyama, Takeyuki Misawa, Hiroshi Arakawa, Mikio Kajihara, Kan Uchiyama, Hiroo Imazu, Seita Koyama, Shunichi Odahara, Shintaro Tsukinaga, Shinji Yoshizaki, Masako Mori, Kazuki Takakura, Masato Okamoto, Sadamu Homma, Shigeo Koido
Purpose: We performed a phase I trial to investigate the safety, clinical responses, and Wilms' tumor 1 (WT1)-specific immune responses following treatment with dendritic cells (DC) pulsed with a mixture of three types of WT1 peptides, including both
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b1e7ef61bbb097bdcc80e48cf0688c0
https://doi.org/10.1158/1078-0432.c.6523221
https://doi.org/10.1158/1078-0432.c.6523221
Autor:
Sei-ichi Yusa1 s-yusa@nihs.go.jp, Oliveira-Martins, José B.2 jose.martins@roche.com, Sugita-Konishi, Yoshiko1 ykonishi@nihs.go.jp, Kikuchi, Yutaka1 kikuchi@nihs.go.jp
Publikováno v:
Viruses (1999-4915). Nov2012, Vol. 4 Issue 11, p3109-3131. 23p. 4 Diagrams, 1 Chart.
Publikováno v:
Viruses
Viruses, Vol 4, Iss 11, Pp 3109-3131 (2012)
Viruses, Vol 4, Iss 11, Pp 3109-3131 (2012)
The human cellular prion protein (PrP(C)) is a glycosylphosphatidylinositol (GPI) anchored membrane glycoprotein with two N-glycosylation sites at residues 181 and 197. This protein migrates in several bands by Western blot analysis (WB). Interesting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6a9cd01c79f732ef9478d99ec5e7ad5
http://europepmc.org/articles/PMC3509686
http://europepmc.org/articles/PMC3509686
Autor:
Iwao Sakonju, Mariko Yamashita, Hiroshi Itoh, Tomoko Kakuta, Ushio Fukushima, Sei-ichi Yusa, Yutaka Horiuchi, Katsuaki Takase, Masato Kuwabara, Teppei Nagasaki, Tsuyoshi Uchide
Publikováno v:
Veterinary immunology and immunopathology. 132(2-4):85-90
The purpose of this study was to evaluate immunological status in dogs with cancers at different stages, in comparison with normal dogs. The population of canine peripheral blood lymphocytes (cPBL), lymphocyte phenotypes, interleukin (IL)-6 activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd0775b3402f4b76bb87004a384844ba
http://hdl.handle.net/10659/2340
http://hdl.handle.net/10659/2340
Publikováno v:
The Journal of Immunology. 172:7385-7392
Human NK cells use class I MHC-binding inhibitory receptors, such as the killer cell Ig-like receptor (KIR) family, to discriminate between normal and abnormal cells. Some tumors and virus-infected cells down-regulate class I MHC and thereby become t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ec15cd014e9579bf121f6b2e85b5999
https://doi.org/10.4049/jimmunol.172.12.7385
https://doi.org/10.4049/jimmunol.172.12.7385